Victoria Hsiao, MD, PhD

Endocrinologist

Dr. Victoria Hsiao is an endocrinologist who specializes in diabetes care and lipid management. She also sees adult patients with other endocrine conditions. Hsiao believes that combining evidence-based medicine with a patient-centered approach brings about the best possible outcomes, particularly with chronic conditions such as diabetes.

Hsiao's areas of special interest include improving the delivery of diabetes care and helping people with diabetes manage daily self-care. She has also studied how health management organization policy can help members control diabetes as well as the impact of high glucose levels after bone marrow transplant.

Hsiao earned her medical degree from Columbia University College of Physicians and Surgeons as well as a doctoral degree in neuropathology from Columbia University. While completing her doctorate, she studied the effects of a mutation found in patients with Alexander disease, a rare neurological disorder. She then completed a residency in internal medicine at the Johns Hopkins Hospital, followed by a fellowship in metabolism, endocrinology and diabetes at the University of Michigan.

Hsiao is a member of the American Diabetes Association and Endocrine Society. She is an associate clinical professor at UCSF.

Clinics

Endocrinology Clinic at Parnassus
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2350
Fax: (415) 353–2337

Hours: Monday to Friday, 8:30 a.m. – 5 pm.

Board Certification

Endocrinology Diabetes & Metab, American Board of Internal Medicine

Academic Title

Associate Professor

More about Victoria Hsiao

Education

Columbia University College of Physicians and Surgeons
Columbia University , Ph.D. Neuropathology

Residencies

Johns Hopkins Hospital , Internal Medicine

Fellowships

University of Michigan Medical Center, Metabolism, endocrinology and diabetes

Selected Research and Publications

  1. Bilik D, McEwen LN, Brown MB, Pomeroy NE, Kim C, Asao K, Crosson JC, Duru OK, Ferrara A, Hsiao VC, Karter AJ, Lee PG, Marrero DG, Selby JV, Subramanian U, Herman WH. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 Oct; 95(10):4560-5.
  2. Bilik D, McEwen LN, Brown MB, Selby JV, Karter AJ, Marrero DG, Hsiao VC, Tseng CW, Mangione CM, Lasser NL, Crosson JC, Herman WH. Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiol Drug Saf. 2010 Jul; 19(7):715-21.
  3. McEwen LN, Hsiao VC, Nota-Kirby EM, Kulpa GJ, Schmidt KG, Herman WH. Effect of a managed care disease management program on diabetes care. Am J Manag Care. 2009 Sep; 15(9):575-80.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.